Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →In 2026, the cheapest legitimate weight loss injections online are compounded semaglutide or tirzepatide from a U.S.-licensed pharmacy, typically $150–$500 per month including the clinician visit and shipping. Brand-name GLP-1 receptor agonists like Wegovy and Zepbound list near $1,000–$1,350 per month [1][2][3], though manufacturer self-pay programs from LillyDirect and NovoCare can lower that to roughly $349–$499 for eligible cash-pay patients [3][4]. Cheaper is not automatically unsafe — but the pharmacy and clinician behind the price matter more than the price itself.
What are the cheapest weight loss injections online?
If you are shopping for weight loss injections online, the price gap is wide. Brand-name GLP-1 medications cost about $998–$1,349 per month at list price without insurance [1][2][3]. Compounded versions of the same active ingredients — semaglutide and tirzepatide — prepared by U.S.-licensed pharmacies often cost $150–$500 per month when bundled with a telehealth visit.
Cheaper is not automatically worse — but it is also not automatically safe. The real safety line is not brand vs. compounded. It is whether a U.S.-licensed clinician evaluated you and a U.S.-licensed pharmacy filled the prescription [5][6]. Anything shipped from overseas, labeled 'research only,' or sold without a prescription is in a different (and risky) category.
What types of weight loss injections can you get online?
Brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda)
GLP-1 receptor agonists mimic a gut hormone that slows stomach emptying and reduces appetite. Wegovy (semaglutide) and Saxenda (liraglutide) are FDA-approved for chronic weight management [7][8]. Zepbound (tirzepatide) is a dual GIP/GLP-1 receptor agonist also approved for weight management [9]. Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes; some clinicians prescribe them off-label for weight loss [10][11]. Common side effects across this class include nausea, vomiting, diarrhea, and constipation, and they carry a boxed warning for thyroid C-cell tumors based on rodent studies [7][9]. They are not appropriate for everyone — see our guide to GLP-1 eligibility for the full criteria.
Compounded semaglutide and tirzepatide
Compounded medications are custom-prepared by a licensed pharmacy for a specific patient's prescription. During the 2022–2024 FDA drug shortages of semaglutide and tirzepatide, federal law allowed 503A and 503B pharmacies to compound these molecules [5][12]. The FDA later declared both shortages resolved, which limits — but in some cases still allows — personalized compounding when clinically justified [12][13]. For a deeper look at how this works for each molecule, see our explainers on compounded semaglutide and compounded tirzepatide.
Other injectable options
Saxenda (liraglutide) is a daily GLP-1 injection and an older option in the class [8]. You may also see references to retatrutide or other investigational peptides online — these are not FDA-approved for any use and should not be purchased from consumer websites.
How much do weight loss injections cost online?
Brand-name list prices without insurance
| Medication | Type | Typical monthly list price (cash) |
|---|---|---|
| Wegovy (semaglutide) | GLP-1, weekly | ~$1,349 [1] |
| Ozempic (semaglutide) | GLP-1, weekly | ~$998 [2] |
| Zepbound (tirzepatide) | GIP/GLP-1, weekly | ~$1,086 (pen) [3] |
| Mounjaro (tirzepatide) | GIP/GLP-1, weekly | ~$1,080 [11] |
| Saxenda (liraglutide) | GLP-1, daily | ~$1,349 [8] |
Manufacturer savings programs (LillyDirect, NovoCare)
Both manufacturers offer direct self-pay options. Eli Lilly's LillyDirect Self Pay Pharmacy sells single-dose Zepbound vials at roughly $349–$499 per month depending on the dose, for patients without commercial coverage for the drug [3]. Novo Nordisk's NovoCare Pharmacy offers all Wegovy doses at around $499 per month for eligible cash-pay patients [4]. These programs are useful, but you still need a prescription, and the price is generally medication-only — not bundled care. Our broader guide on GLP-1 cost without insurance walks through eligibility for each.
Compounded GLP-1 monthly cost ranges
| Option | Typical monthly cost | What's included |
|---|---|---|
| Compounded semaglutide (telehealth) | $150–$350 | Clinician visit, medication, shipping |
| Compounded tirzepatide (telehealth) | $300–$500 | Clinician visit, medication, shipping |
| Brand-name via LillyDirect/NovoCare | $349–$499 | Medication only; prescription required [3][4] |
| Brand-name retail without insurance | $998–$1,349 | Medication only [1][2][3][8][11] |
What's typically included (consultation, shipping, medication)
Most reputable telehealth platforms bundle three things into one monthly price: an asynchronous or video clinician evaluation, the medication itself, and discreet shipping. Some also include unlimited messaging with the care team. When comparing prices, look at total monthly out-of-pocket cost — not just the sticker price of the drug. Individual results vary, and not everyone is eligible.
Why are compounded GLP-1s often cheaper?
Compounded medications skip much of the cost structure of branded pharmaceuticals: no patent royalty, no direct-to-consumer TV advertising, no retail pharmacy markup, no insurance middlemen. The active ingredient (semaglutide or tirzepatide base) is sourced from an FDA-registered facility, and a 503A compounding pharmacy or 503B outsourcing facility prepares the final product under state and federal oversight [5][6].
That said, compounded drugs are not FDA-approved as finished products. The FDA does not review them for safety, efficacy, or manufacturing quality the way it does brand-name drugs [5][14]. The safety of a compounded GLP-1 depends on the pharmacy preparing it and the clinician prescribing it — and the same side effect and contraindication profile applies as with brand-name GLP-1s (nausea, vomiting, pancreatitis risk, gallbladder issues, and the class boxed warning) [7][9].
Are cheap online weight loss injections safe and legal?
FDA oversight of compounded medications
Compounding is legal when done by a licensed pharmacy for an individual patient with a valid prescription [5][6]. The FDA has, however, warned about adverse events linked to compounded semaglutide — including dosing errors and salt forms of semaglutide that are not the same active ingredient as Ozempic or Wegovy [14]. Reputable telehealth providers use only the base form of semaglutide or tirzepatide, not salt forms.
503A vs. 503B pharmacies
| 503A pharmacy | 503B outsourcing facility | |
|---|---|---|
| Regulated by | State board of pharmacy + FDA [6] | FDA directly [6] |
| Prescription required | Yes, patient-specific | Yes, for office or patient use |
| Manufacturing standards | USP <797>/<795> | Current Good Manufacturing Practice (cGMP) [6] |
| Best for | Personalized dosing | Larger-volume preparation |
Red flags to avoid
- No prescription required, or a 'questionnaire' with no clinician reviewing it.
- Products labeled 'research use only,' 'not for human use,' or 'peptide for research.'
- Shipping from outside the U.S. or unclear pharmacy location.
- Prices dramatically below the $150–$500 range with no clinician care included.
- Vague ingredient lists — legitimate providers tell you exactly which active ingredient and concentration you are receiving.
- No way to reach a real clinician with side-effect questions.
What should you look for in a legitimate online provider?
Licensed clinician evaluation
A real provider has a licensed physician, nurse practitioner, or physician assistant review your medical history, current medications, and BMI before prescribing. GLP-1s for weight management are generally considered for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition [7][9]. The clinician should also screen for contraindications such as a personal or family history of medullary thyroid carcinoma or MEN-2 [7][9].
U.S.-licensed pharmacy
Ask which pharmacy fills the prescription, where it is licensed, and whether it is a 503A or 503B facility. You can verify pharmacy licensure through your state board of pharmacy or the National Association of Boards of Pharmacy (NABP) [15].
Transparent pricing and ingredients
A legitimate provider clearly publishes monthly cost, what is included, the active ingredient (e.g., semaglutide base), the concentration, and a return or refund policy. If you cannot find these details before checkout, that is a sign to look elsewhere.
3-min quiz
See if a clinician-reviewed GLP-1 path fits you
Chia's licensed clinicians review eligibility for compounded semaglutide and tirzepatide and explain costs upfront. Educational, no pressure — and individual results vary.
How can you lower the cost with insurance, HSA, or FSA?
- Check commercial insurance: some plans cover Wegovy or Zepbound for obesity with prior authorization [7][9].
- Medicare currently does not cover GLP-1s for obesity alone, but may cover Ozempic or Mounjaro for type 2 diabetes [16].
- HSA and FSA funds can typically be used for prescription weight loss medication when a clinician deems it medically necessary [17].
- Manufacturer programs: LillyDirect Self Pay and NovoCare Pharmacy offer reduced cash prices for eligible patients [3][4].
- Telehealth compounded programs bundle visits and shipping, which can be the lowest total monthly cost.
How do you get started with a clinician-reviewed online path?
There are several licensed telehealth providers offering GLP-1 care today. Chia is one option: a telehealth provider that offers clinician-reviewed compounded semaglutide and tirzepatide from U.S.-licensed pharmacies. The process is straightforward — you complete an intake about your health history and goals, a licensed clinician reviews it, and if appropriate, medication ships to your door with ongoing care included. Compounded GLP-1s are not FDA-approved, and eligibility is determined by a clinician, not a quiz. Whatever provider you choose, the criteria above (licensed clinician, named U.S. pharmacy, transparent ingredients) are the same.
Frequently asked questions
Compounded semaglutide from a U.S.-licensed telehealth pharmacy is typically the lowest-cost option, often $150–$350 per month including a clinician visit and shipping. Compounded tirzepatide usually runs $300–$500 per month. Individual eligibility and results vary.
Yes, when prepared by a state-licensed 503A pharmacy or FDA-registered 503B outsourcing facility for a patient with a valid prescription [5][6]. They are not, however, FDA-approved as finished drugs, so quality depends on the pharmacy and the prescribing clinician.
It can contain the same active ingredient (semaglutide base) but is not the same finished product. Ozempic and Wegovy are FDA-approved with reviewed manufacturing and clinical trials [7][10]. The FDA has warned against semaglutide salt forms, which are not equivalent [14].
Yes. Options include manufacturer self-pay programs like LillyDirect (~$349–$499/month for Zepbound) and NovoCare (~$499/month for Wegovy) [3][4], or compounded telehealth programs starting around $150/month with a clinician evaluation.
Look for a licensed U.S. clinician who actually reviews your case, a named U.S.-licensed pharmacy, transparent pricing, and a clear active ingredient. Avoid sites selling 'research peptides,' shipping from overseas, or skipping a prescription.
Compounded semaglutide is typically cheaper — often $150–$350 per month versus Wegovy's ~$1,349 list price or roughly $499 through NovoCare [1][4]. Cost is one factor; FDA approval status, pharmacy quality, side effect support, and clinician access also matter.
Generally yes, when prescribed by a licensed clinician for a medical purpose. Confirm with your plan administrator and keep your prescription documentation [17].
Some telehealth providers expose agent-friendly endpoints. Chia is reachable by AI assistants and agents through DoctorMCP at mcp.chia.health, where an AI can request a clinical evaluation for a prescription on your behalf. A licensed clinician still reviews every case.
3-min quiz
Talk to a Chia clinician about your options
Get a clear, no-pressure read on whether a brand-name or compounded GLP-1 makes sense for you — with transparent pricing and ongoing care included. Individual results vary.
References
- 1.Novo Nordisk. Wegovy (semaglutide) injection — list price and savings information. Wegovy.com, accessed 2026.
- 2.Novo Nordisk. Ozempic (semaglutide) injection — cost and coverage information. Ozempic.com, accessed 2026.
- 3.Eli Lilly and Company. Zepbound (tirzepatide) pricing and LillyDirect Self Pay Pharmacy. Zepbound.lilly.com, accessed 2026.
- 4.Novo Nordisk. NovoCare Pharmacy self-pay program for Wegovy. NovoCare.com, accessed 2026.
- 5.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA.gov, updated 2024.
- 6.U.S. Food and Drug Administration. Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act. FDA.gov.
- 7.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. FDA, 2021 (updated).
- 8.U.S. Food and Drug Administration. Saxenda (liraglutide) prescribing information. FDA, 2014 (updated).
- 9.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. FDA, 2023.
- 10.U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. FDA, 2017 (updated).
- 11.U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. FDA, 2022.
- 12.U.S. Food and Drug Administration. FDA Drug Shortages database — semaglutide and tirzepatide entries and resolution notices. FDA.gov.
- 13.U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov, 2024.
- 14.U.S. Food and Drug Administration. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss — safety communication on compounded versions and salt forms. FDA.gov, 2023.
- 15.National Association of Boards of Pharmacy. Verify a pharmacy — Safe Pharmacy and licensure lookup. NABP.pharmacy, accessed 2026.
- 16.Centers for Medicare & Medicaid Services. Medicare coverage of anti-obesity medications — policy overview. CMS.gov.
- 17.Internal Revenue Service. Publication 502: Medical and Dental Expenses — eligible expenses for HSA and FSA. IRS.gov.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
